共 191 条
[1]
Addou-Klouche L(2010)Loss, mutation and deregulation of L3MBTL4 in breast cancers Mol Cancer 9 213-2149
[2]
Adelaide J(2010)Subcellular localization of activated AKT in estrogen receptor- and progesterone receptor-expressing breast cancers: potential clinical implications Am J Pathol 176 2139-1633
[3]
Finetti P(2010)Estrogen receptor-alpha phosphorylation at serine 305, nuclear p21-activated kinase 1 expression, and response to tamoxifen in postmenopausal breast cancer Clin Cancer Res 16 1624-406
[4]
Cervera N(2013)Activation of Akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefit Breast Cancer Res Treat 137 397-246
[5]
Ferrari A(2014)Characterization of PTPN2 and its use as a biomarker Methods 65 239-9824
[6]
Bekhouche I(2001)Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance J Biol Chem 276 9817-3869
[7]
Sircoulomb F(2002)Genomic loss of 18p predicts an adverse clinical outcome in patients with high-risk breast cancer Clin Cancer Res 8 3863-2108
[8]
Sotiriou C(2003)Regulation of insulin receptor signaling by the protein tyrosine phosphatase TCPTP Mol Cell Biol 23 2096-829
[9]
Viens P(2005)Coordinated regulation of insulin signaling by the protein tyrosine phosphatases PTP1B and TCPTP Mol Cell Biol 25 819-1246
[10]
Moulessehoul S(2014)Protein tyrosine phosphatases as potential therapeutic targets Acta Pharmacol Sin 35 1227-3616